PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Delamanid - Tuberculosis
PAD Profile : Delamanid - Tuberculosis
Keywords :
extensively drug resistant TB, multi drug resistant TB, antibiotic, antibacterial
Brand Names Include :
Deltyba
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Ethambutol hydrochloride
- Isoniazid
- Pyrazinamide
- Rifampicin
- Bedaquiline
- Para-aminosalicylic acid
- Pretomanid
- Capreomycin
- Cycloserine
- Rifampicin with ethambutol, isoniazid and pyrazinamide
- Rifampicin with isoniazid
- Rifampicin with isoniazid and pyrazinamide
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
16 April 2018
Not Set
This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.
Associated BNF Codes
05. Infections
05.01.09. Antituberculosis drugs